Business · 27/10/2015
FDA Establishes Public Docket for Bulk Drug Substances for Compounding Drug Products
The FDA is developing a list of bulk drug substances that can be used to compound drug products in accordance with the FD&C Act, and is now establishing a public docket for interested parties to submit nominations and comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →